
Only 20 new molecular entities passed muster this year, less than half of 2015’s total
Only 20 new molecular entities passed muster this year, less than half of 2015’s total
New consumer-education campaign led by Alliance for Safe Online Pharmacies
A preamble for a next round of legislating drug pricing?
Action is expected to meet FTC objections to the merged chains announced in 2015
Back to square one in addressing high-cost-drug spending
Connecticut leads 20 states suing an alleged ring led by Heritage Pharma
First branded-product discount program from Blink Health
Higher productivity and more complexity; but slow takeup of traceability requirements
Growth rates will moderate in the US and world
Bills passes House with broad bipartisan support; Senate approval likely
A counterargument to the belief that out-of-pocket expenses originate with insurers or PBMs
Sale comes with multi-year supply agreement
Two Canadian Accucaps facilities join global network of 11 Catalent RP Scherer Softgel locations
Allergan’s big commitment to NJ; U. of Michigan converts pharma facilities to healthcare and education
Upcoming trial could explore the intricacies of ‘alternative fulfillment’ via specialty pharmacies
An Amazon-like model for creating an open market for wholesalers to reach customers
Will employer benefit plans lose their enthusiasm for PBMs?
Revenues and earnings were up for the year; stock jumps 8.8% in the day
McKesson disappoints on Q2 earnings call; stock drops 23%. Update: Cardinal reports more revenue, less profit
Price growth is less than branded growth, but higher than inflation
Company may have erroneously been operating under a generic classification
New company is to be known as QuintilesIMS
Drug dispensing, point of care testing and diagnostics are beneficiaries
Drug Channel’s analysis of Inc. 5000 shows some eye-popping growth